Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

2.

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends.

Jørgensen KJ, Gøtzsche PC.

BMJ. 2009 Jul 9;339:b2587. doi: 10.1136/bmj.b2587. Review.

3.

Mammographic screening for breast cancer. Overdiagnosis: an insidious adverse effect of screening.

[No authors listed]

Prescrire Int. 2015 Jul;24(162):186-9, 191. Review.

PMID:
26240891
4.

The other side of technology: risk of overdiagnosis of breast cancer with mammography screening.

Puliti D, Paci E.

Future Oncol. 2009 May;5(4):481-91. doi: 10.2217/fon.09.25. Review.

PMID:
19450177
5.

Screening for breast cancer with mammography.

Gøtzsche PC, Nielsen M.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001877. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD001877.

PMID:
17054145
6.

Why mammography screening has not lived up to expectations from the randomised trials.

Gøtzsche PC, Jørgensen KJ, Zahl PH, Mæhlen J.

Cancer Causes Control. 2012 Jan;23(1):15-21. doi: 10.1007/s10552-011-9867-8. Epub 2011 Nov 10. Review.

PMID:
22072221
7.
8.

Overdiagnosis of breast cancer at screening is clinically insignificant.

Feig SA.

Acad Radiol. 2015 Aug;22(8):961-6. doi: 10.1016/j.acra.2015.01.020. Epub 2015 Mar 18. Review.

PMID:
25797300
9.

Breast cancer screening.

Jatoi I.

Am J Surg. 1999 Jun;177(6):518-24. Review.

PMID:
10414706
10.

Why question screening mammography for women in their forties?

Fletcher SW.

Radiol Clin North Am. 1995 Nov;33(6):1259-71. Review.

PMID:
7480669
11.

Implications of Overdiagnosis: Impact on Screening Mammography Practices.

Morris E, Feig SA, Drexler M, Lehman C.

Popul Health Manag. 2015 Sep;18 Suppl 1:S3-11. doi: 10.1089/pop.2015.29023.mor. Review.

12.

Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.

Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E; EUROSCREEN Working Group.

J Med Screen. 2012;19 Suppl 1:42-56. Review.

PMID:
22972810
13.

Interpreting overdiagnosis estimates in population-based mammography screening.

de Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ.

Epidemiol Rev. 2011;33:111-21. doi: 10.1093/epirev/mxr009. Epub 2011 Jun 27. Review.

14.

Mammographic screening: evidence from randomised controlled trials.

de Koning HJ.

Ann Oncol. 2003 Aug;14(8):1185-9. Review.

PMID:
12881373
15.

Position paper: breast cancer screening, diagnosis, and treatment in Denmark.

Christiansen P, Vejborg I, Kroman N, Holten I, Garne JP, Vedsted P, Møller S, Lynge E.

Acta Oncol. 2014 Apr;53(4):433-44. doi: 10.3109/0284186X.2013.874573. Epub 2014 Feb 5. Review.

PMID:
24495043
16.

Breast cancer screening among women in their forties: an overview of the issues.

Fletcher SW.

J Natl Cancer Inst Monogr. 1997;(22):5-9. Review.

PMID:
9709267
17.

[Screening mammography for early diagnosis of breast cancer: facts, controversies, and the implementation in Israel].

Allweis TM, Nissan A, Spira RM, Sklair-Levy M, Freund HR, Peretz T.

Harefuah. 2003 Apr;142(4):281-6, 317. Review. Hebrew.

PMID:
12754879
18.

Screening for breast cancer with mammography.

Olsen O, Gøtzsche PC.

Cochrane Database Syst Rev. 2001;(4):CD001877. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD001877.

PMID:
11687128
19.

[Natural history of breast cancer: a systematic review of worldwide randomized controlled trials of mammography screening].

Yue XP, Shi JF, Mao AY, Wang L, Ma HM, Chen LL, Zhu J, Cheng X, Dai M.

Zhonghua Zhong Liu Za Zhi. 2017 Feb 23;39(2):154-160. doi: 10.3760/cma.j.issn.0253-3766.2017.02.017. Review. Chinese.

PMID:
28219215
20.

[Screening for breast cancer: worries about its effectiveness].

Autier P.

Rev Prat. 2013 Dec;63(10):1369-77. Review. French.

PMID:
24579331

Supplemental Content

Support Center